On the latest On Record, @yaelmaxwell.bsky.social, Gilbert Tang, and Tsuyoshi Kaneko discuss reinterventions after TAVI during #NYValves2025. Watch the full video here: www.tctmd.com/videos/on-re...

In this episode of Talking Points, Kendra Grubb, Sean Pinney, and JoAnn Lindenfeld discuss the impact of transcatheter devices on HF patients and current barriers faced by referring specialists at #NYValves2025. www.tctmd.com/audio/tmvr-h...

On this episode of Talking Points, Kendra Grubb, Tim Byrne, and Hussam Suradi discuss the importance of patient selection for transcatheter interventions and defining treatment goals at #NYValves2025. www.tctmd.com/audio/patien...

During #NYValves2025, Patrick O'Gara, Michael Borger, and @yaelmaxwell.bsky.social discussed how the FDA approval of asymptomatic TAVI has changed practice, with perspectives from the US and Europe. Watch the full episode of On Record here: www.tctmd.com/videos/on-re...

The Intrepid TMVR system just released 2-year transfemoral EFS outcomes at #NYValves2025, featuring Kendra Grubb, Gilbert Tang, & Firas Zahr. Listen to this Talking Points episode for more on what this data means for the Intrepid mitral program: www.tctmd.com/audio/insigh...

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed The data indicate it’s worth a shot to try TEER in many with secondary MR, but clinical judgement is critical.

New findings presented at #NYValves2025 found that MitraClip was safe and effective for those who did not meet the criteria for the COAPT study. This could potentially make M-TEER an option for certain patients with secondary MR and advanced heart disease. www.tctmd.com/news/mitracl...

In this episode of Heart Valve Matters, Isaac George talks about the one-year clinical results of the novel polymeric leaflet TRIA valve for patients undergoing surgical mitral valve replacement, which he presented at this year's #NYValves2025. www.tctmd.com/audio/mitral...

Solid, Early Surgical Results With Polymer Mitral Valve A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say surgeons.

Positive early results for a robotically-made polymer surgical valve show an “acceptable safety” profile and stable hemodynamics through 1 year of follow-up in younger patients with symptomatic mitral valve disease. Read more about this innovative device: www.tctmd.com/news/solid-e... #NYValves2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL The results suggest minimal health status benefits once TR has dropped by three grades, but further research is needed.

Patients who underwent TTVI saw health status improvements, including quality of life, that mirrored the degree of TR reduction. The findings are promising, but further research is needed. Read about the study's results presented at this year's #NYValves2025. www.tctmd.com/news/changes...

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.

For patients with degenerative MR, early survival outcomes are good when TEER is paired with the Pascal system, reducing MR and improving quality of life. Read more: www.tctmd.com/news/good-ou... #NYValves2025

No Benefit of Sentinel Device During TAVI: Updated Meta-analysis Some believe that future studies are still needed to tease out whether there are high-risk subgroups who will benefit.

www.tctmd.com/news/no-bene... #CardioSky #NYValves2025 @toddneale.bsky.social

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data The procedures are not mutually exclusive, however, and should be considered on a patient-by-patient basis, a researcher says.

Long-term survival is better with a surgical explant after TAVI compared with redo transcatheter procedures, according to new Medicare data presented at the recent #NYValves2025. Procedures should be done case-by-case, but promising for younger patients choosing TAVR. www.tctmd.com/news/long-te...

Alerts to Physicians Close Gaps in AS Management Between Women, Men In DETECT AS, the passive notifications improved rates of AVR and boosted survival, with bigger gains in women.

Electronic alerts about the management of severe AS sent to physicians have greater benefits for female versus male patients, according to an analysis of the DETECT AS trial presented at #NYValves2025. Read more on how it can address some known disparities in women. www.tctmd.com/news/alerts-...

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World The study led to questions about whether patients would be best served by being treated at high-volume centers of excellence.

TEER with the Pascal system in patients with degenerative MR results in good early survival outcomes, significant reductions in MR, and improvements in quality of life, according to an analysis of the STS/ACC TVT Registry. #NYValves2025 #CardioSky

www.tctmd.com/news/good-ou...

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data The procedures are not mutually exclusive, however, and should be considered on a patient-by-patient basis, a researcher says.

My 1st from #NYValves2025 (and my 1st time at this meeting!):

Surgical explant is associated with better long-term survival compared with redo TAVI in a population of Medicare patients requiring reintervention. @ShinFukuharaMD @DrBowdish @TsuyoshiKaneko1

www.tctmd.com/news/long-te...

Another successful #NYValves2025 is in the books! Explore all the news, slides, and videos from this year's structural heart conference in NYC by visiting TCTMD. www.tctmd.com/nyvalves2025

Failure of ‘Jailed’ CIED Leads Not Uncommon After TTVR: TRIPLACE The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

www.tctmd.com/news/failure... #CardioSky #NYValves2025 @toddneale.bsky.social

ASE members, Lucy Safi, DO, FASE and Rebecca Hahn, MD, FASE, present during Cardiovascular Research Foundation's #NYValves2025!

🌟 It’s the last day of #NYValves2025. Let’s finish strong! 🫀 Dive into late-breaking data, live cases, interactive learning, and meaningful connections. Don’t miss your final chance to be part of the action! 💡 www.nyvalvesconference.com/program-guid...

#CardioSky

We're on Day 2 of #NYValves2025 with late-breaking clinical trials, live cases, and more! Access the latest content from this year's structural heart conference in NYC on TCTMD: www.tctmd.com/nyvalves2025

ASE member, Renuka Jain, MD, FASE, presents the case "Moderate AR, Moderate AS" during "iCOACH Session 11: Heart Team in Action II: Mixed and Multi-Valve Disease Cases at Cardiovascular Research Foundation's #NYValves2025!

🚀 Get ready for Day 2 at #NYValves2025! Dive into breakthrough science, live cases, and game-changing innovations designed to elevate your practice. There’s truly something for every #HeartTeam member!

www.nyvalvesconference.com/program-guid...

#CardioSky

Alerts to Physicians Close Gaps in AS Management Between Women, Men In DETECT AS, the passive notifications improved rates of AVR and boosted survival, with bigger gains in women.

www.tctmd.com/news/alerts-... #NYValves2025 #CardioSky

#NYValves2025 brings together leaders in structural heart disease: interventionalists, imagers, surgeons & HF specialists.

📚 Browse groundbreaking #JACCJournals research published to coincide with meeting presentations 👉 www.jacc.org/events/confe...

#JACC #JACCINT #JACCIMG #JACCHF #JACCCaseReports

Kicking off #NYValves2025 with a full day of hands-on learning and dynamic sessions for the entire #HeartTeam! 💥

🔎 Explore Wednesday’s lineup:
www.nyvalvesconference.com/program-guid...

🫀
Join the conversation and stay updated with real-time highlights, breakthroughs, and education in structural heart disease.
📍 3 days. 💡 Big insights. 🚀

#CardioSky #NYValves2025

#NYValves2025 kicks off tomorrow! Don’t miss a moment! Explore the program guide and map out your must-attend sessions. Let’s advance structural heart care, together. 🫀✨

📅 Plan your time now! www.nyvalvesconference.com/program-guide

#CardioSky

#NYValves2025 is almost here! 🚨 Stay connected with real-time updates, expert takeaways, and behind-the-scenes moments from our Social Media Ambassadors. Follow along for the latest from the frontlines of innovation! 🔗 www.nyvalvesconference.com/social-media...

#CardioSky

🚨 It all begins tomorrow! #NYValves2025 is almost here. 🗽Join us in NYC for the premier structural heart meeting — featuring groundbreaking science, live cases, hands-on learning, and global collaboration.

There’s still time to join us! nyvalvesconference.com/register

#CardioSky #MedSky

The big day arrives tomorrow! Join us at #NYValves2025 where we'll be featuring groundbreaking science, live cases, hands-on learning, and global collaboration. Become a part of NYC's premier structural heart conference by registering now! nyvalvesconference.com/register #interventionalcardiology